X4 Pharmaceuticals XFOR
NASDAQ XFOR
$2.83 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

X4 Pharmaceuticals (XFOR) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

X4 Pharmaceuticals (XFOR) reported Return on Capital Employed [ROCE] of -36.28% for Q2 2026, up 75.54 percentage points from -111.82% a year earlier and up 1.81 percentage points from the prior quarter.

Analysis

X4 Pharmaceuticals (XFOR) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, X4 Pharmaceuticals posted Return on Capital Employed [ROCE] of -45.09%, down 13.15 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of +1.03 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -31.94% in FY2024 (+51.70 pp), -83.64% in FY2023 (-6.86 pp), -76.78% in FY2022 (+3.51 pp) and -80.29% in FY2021 (-34.17 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since Q1 2025.
  • Year over year, Return on Capital Employed [ROCE] gained in four of the last eight quarters, with an average year-over-year change of +8.41 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2025 (a gain of 101.17 percentage points); the low point was Q2 2025 (a drop of 97.79 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -38.09% (Q1 2026), -43.17% (Q4 2025) and -89.21% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 X4 Pharmaceuticals 357.55 Mn -341.13 Mn 7.19 Mn -36.28%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -36.28%
Mar 31, 2026 -38.09%
Dec 31, 2025 -43.17%
Sep 30, 2025 -89.21%
Jun 30, 2025 -111.82%
Mar 31, 2025 -7.61%
Dec 31, 2024 -28.12%
Sep 30, 2024 -15.68%
Jun 30, 2024 -14.04%
Mar 31, 2024 -108.79%
Dec 31, 2023 -78.25%
Sep 30, 2023 -72.95%
Jun 30, 2023 -79.62%
Mar 31, 2023 -79.33%
Dec 31, 2022 -78.07%
Sep 30, 2022 -132.92%
Jun 30, 2022 -131.75%
Mar 31, 2022 -94.66%
Dec 31, 2021 -81.19%
Sep 30, 2021 -62.54%
API Access

X4 Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=XFOR&period=max&api_key=YOUR_API_KEY